ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Recs

0
Player Avatar julianna8 (< 20) Submitted: 10/5/2010 5:26:12 AM : Outperform Start Price: $8.14 ISIS Score: +5.20

great price!

Featured Broker Partners


Advertisement